Activation	O
-	O
induced	O
cytidine	O
deaminase	O
in	O
antibody	O
diversification	O
and	O
chromosome	B-Cellular_component
translocation	O
.	O

DNA	O
damage	O
,	O
rearrangement	O
,	O
and	O
mutation	O
of	O
the	O
human	O
genome	O
are	O
the	O
basis	O
of	O
carcinogenesis	O
and	O
thought	O
to	O
be	O
avoided	O
at	O
all	O
costs	O
.	O

An	O
exception	O
is	O
the	O
adaptive	O
immune	B-Anatomical_system
system	I-Anatomical_system
where	O
lymphocytes	B-Cell
utilize	O
programmed	O
DNA	O
damage	O
to	O
effect	O
antigen	O
receptor	O
diversification	O
.	O

Both	O
B	B-Cell
and	O
T	B-Cell
lymphocytes	I-Cell
diversify	O
their	O
antigen	O
receptors	O
through	O
RAG1	O
/	O
2	O
mediated	O
recombination	O
,	O
but	O
B	B-Cell
cells	I-Cell
undergo	O
two	O
additional	O
processes	O
-	O
-	O
somatic	O
hypermutation	O
(	O
SHM	O
)	O
and	O
class	O
-	O
switch	O
recombination	O
(	O
CSR	O
)	O
,	O
both	O
initiated	O
by	O
activation	O
-	O
induced	O
cytidine	O
deaminase	O
(	O
AID	O
)	O
.	O

AID	O
deaminates	O
cytidines	O
in	O
DNA	O
resulting	O
in	O
U	O
:	O
G	O
mismatches	O
that	O
are	O
processed	O
into	O
point	O
mutations	O
in	O
SHM	O
or	O
double	O
-	O
strand	O
breaks	O
in	O
CSR	O
.	O

Although	O
AID	O
activity	O
is	O
focused	O
at	O
Immunoglobulin	O
(	O
Ig	O
)	O
gene	O
loci	O
,	O
it	O
also	O
targets	O
a	O
wide	O
array	O
of	O
non	O
-	O
Ig	O
genes	O
including	O
oncogenes	O
associated	O
with	O
lymphomas	B-Cancer
.	O

Here	O
,	O
we	O
review	O
the	O
molecular	O
basis	O
of	O
AID	O
regulation	O
,	O
targeting	O
,	O
and	O
initiation	O
of	O
CSR	O
and	O
SHM	O
,	O
as	O
well	O
as	O
AID	O
'	O
s	O
role	O
in	O
generating	O
chromosome	B-Cellular_component
translocations	O
that	O
contribute	O
to	O
lymphomagenesis	O
.	O

